GLORIA

GEOMAR Library Ocean Research Information Access

feed icon rss

Your email was sent successfully. Check your inbox.

An error occurred while sending the email. Please try again.

Proceed reservation?

Export
  • 1
    Electronic Resource
    Electronic Resource
    Springer
    Journal of molecular evolution 19 (1983), S. 171-175 
    ISSN: 1432-1432
    Keywords: Amino acid substitution ; Protein evolution ; Conservation of secondary structure ; Hydrophobicity ; Bulk ; Multidimensional scaling
    Source: Springer Online Journal Archives 1860-2000
    Topics: Biology
    Notes: Summary It is commonly recognised that many evolutionary changes of amino acid sequence in proteins are conservative: a substitution of one amino acid residue for another has a far greater chance of being accepted if the two residues are similar in properties. Here we investigate what properties are most important in determining the similarity of two amino acids, from the evolutionary point of view. Our results confirm earlier observations that the hydrophobicity and the molecular bulk of the side chain tend to be conserved. More importantly they also show that evolutionary pressures favour the conservation of secondary structure, and that all these properties can be arranged in a two dimensional diagram in which distances well preserve the observed substitution frequencies between amino acids. These results were obtained by a multi-dimensional scaling technique; and are independent of any prior opinions about conserved properties. Thus, it is demonstrated that all relations of importance to single amino acid substitutions can be represented by a single figure, which is much more comprehensible and useful than the usual tabular representation of substitution frequencies. Such a figure conveniently portrays the “stereochemical code” for conservative substitution.
    Type of Medium: Electronic Resource
    Location Call Number Limitation Availability
    BibTip Others were also interested in ...
  • 2
    Publication Date: 2013-09-21
    Description: Targeted therapies provide clinical benefit and improved therapeutic index. They have a growing prominence in patient management and focus in drug development. Their development is fuelled by our deepening knowledge of complex disease phenotypes and the need for improvement in new therapeutic efficacy. Extrapolation of the biological discovery through to new therapy targeting the causal biological variants to drive clinical gain is challenging. Here, we review the impact of germline mutations on targeted therapies. Historically, germline changes have contributed most to our understanding of disease mechanisms, and drug metabolism and exposure, the latter of which has enabled safer positioning of therapies, such as clopidogrel and irinotecan. Similarly, pre-screening for germline variants can avoid potentially fatal hypersensitivity reactions with abacavir. However, germline mutations continue to emerge as a central player in targeting therapeutics; ivacaftor drives partial restoration of mucus secretion in cystic fibrosis patients harbouring specific mutations and treatment with olaparib exploits germline mutations in BRCA genes to drive synthetic lethality as an anti-cancer mechanism. Central is definition of the causal link, association or contribution to the biological variance – and that we believe it is drugable for therapeutic gain. The demand for better therapies to treat modern diseases provides the appetite for continued investigation of the biologic variance associated with germline mutation, inevitably leading to increased impact on development of targeted therapeutics.
    Print ISSN: 0022-3417
    Electronic ISSN: 1096-9896
    Topics: Medicine
    Published by Wiley-Blackwell
    Location Call Number Limitation Availability
    BibTip Others were also interested in ...
Close ⊗
This website uses cookies and the analysis tool Matomo. More information can be found here...